GABAシグナリング 糖尿病マウスのβ細胞再生を刺激する
Gordon C Weir1, Susan Bonner-Weir1
1Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
Cell
|January 14, 2017
まとめ
ガンマアミノバター酸 (GABA) とアルテメテルは,臓のアルファ細胞をベータ細胞に変換することができます. この発見は インスリンを産生する 新しい細胞を生成することで 重度の糖尿病を治療する 新しい方法を提示しています
科学分野:
- 内分泌学
- 細胞生物学
- 薬理学について
背景:
- 臓の小島細胞,特にアルファ細胞とベータ細胞は,グルコースホメオスタシスにおいて重要な役割を果たします.
- 糖尿病はインスリン産生や機能が低下し,高血糖症を引き起こす.
- GABAergic経路とその調節は,代謝障害の潜在的な治療目標です.
研究 の 目的:
- 臓のアルファ細胞をベータ細胞フェノタイプへと再プログラムするGABAとアルテメターの可能性を調査する.
- 糖尿病治療のための機能的なベータ細胞生成におけるこれらの薬剤の有効性を評価する.
主な方法:
- 既知の研究論文を用いて (Ben-Othman et al. そして Li et al.) 実験結果の詳細を記載しています
- 臨床前モデルにおけるGABAとアルテメタの臓細胞の分化への影響を分析した.
主要な成果:
- GABAとアルテメテルは,臓のアルファ細胞の表型変化を誘発し,ベータ細胞のような状態を促進することが示された.
- これらの治療は,十分な数の新しいベータ細胞の生成を刺激しました.
- これらの薬の投与はマウスモデルで重度の糖尿病を成功裏に逆転させました.
結論:
- GABAとアルテメテルは,機能的なベータ細胞に pancreasのアルファ細胞を再プログラムする重要な能力を示しています.
- この細胞の再プログラムが 重度の糖尿病の治療に 新しい戦略を提示します
- GABAergicとアルテメーター媒介経路に関するさらなる研究は,糖尿病管理のための新しい治療の道を開くことができます.
さらに関連する動画
関連する概念動画
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.9K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.9K
Hormones Regulating Blood Glucose
7.8K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.8K
Insulin Secretory Vesicles
7.2K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K
Tissue Renewal without Stem Cells
2.2K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
2.2K
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K


